| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.26B | 53.06B | 50.31B | 52.51B | 45.41B | 39.20B |
| Gross Profit | 14.49B | 15.36B | 14.39B | 16.41B | 12.51B | 6.58B |
| EBITDA | 6.42B | 7.07B | 7.49B | 11.21B | 8.51B | 6.28B |
| Net Income | 883.00M | 1.79B | 2.33B | 6.18B | 5.46B | 1.98B |
Balance Sheet | ||||||
| Total Assets | 72.78B | 72.57B | 67.03B | 65.08B | 61.67B | 63.09B |
| Cash, Cash Equivalents and Short-Term Investments | 12.98B | 15.88B | 12.30B | 10.29B | 10.36B | 16.71B |
| Total Debt | 28.85B | 29.55B | 26.15B | 27.25B | 27.13B | 35.72B |
| Total Liabilities | 41.87B | 43.39B | 39.64B | 41.02B | 41.60B | 49.53B |
| Stockholders Equity | 30.89B | 29.17B | 27.37B | 24.04B | 20.04B | 13.55B |
Cash Flow | ||||||
| Free Cash Flow | 208.00M | 2.44B | 4.77B | 3.29B | 2.12B | -2.15B |
| Operating Cash Flow | 4.08B | 6.11B | 8.53B | 6.56B | 4.56B | 124.00M |
| Investing Cash Flow | -6.26B | -4.45B | -3.81B | -3.23B | -2.33B | 313.00M |
| Financing Cash Flow | 3.60B | 1.91B | -2.95B | -3.52B | -8.91B | 5.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥7.36T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
70 Outperform | ¥39.80B | 10.46 | ― | 4.53% | -2.57% | 3.43% | |
67 Neutral | ¥4.21T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
62 Neutral | ¥31.01B | 20.49 | ― | 2.86% | 2.87% | -53.44% | |
62 Neutral | ¥8.63B | 65.95 | ― | 1.78% | -1.17% | -42.36% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥610.73B | 15.62 | ― | 2.57% | 4.81% | -49.43% |